HighPoint Advisor Group LLC Increases Stock Position in Roche Holding AG (OTCMKTS:RHHBY)

HighPoint Advisor Group LLC increased its position in Roche Holding AG (OTCMKTS:RHHBY) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,091 shares of the company’s stock after buying an additional 304 shares during the quarter. HighPoint Advisor Group LLC’s holdings in Roche were worth $387,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Hantz Financial Services Inc. increased its holdings in Roche by 0.9% in the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after purchasing an additional 305 shares in the last quarter. Brooklyn Investment Group boosted its holdings in Roche by 36.6% in the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock valued at $48,000 after purchasing an additional 363 shares during the last quarter. Altrius Capital Management Inc grew its stake in Roche by 0.3% during the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock valued at $6,399,000 after purchasing an additional 603 shares in the last quarter. Diversified Trust Co increased its holdings in Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after purchasing an additional 711 shares during the last quarter. Finally, Verity Asset Management Inc. raised its position in shares of Roche by 26.8% in the 4th quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock valued at $280,000 after purchasing an additional 1,697 shares in the last quarter.

Roche Stock Performance

Roche stock opened at $39.37 on Thursday. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $44.31. The company has a fifty day moving average price of $41.37 and a two-hundred day moving average price of $38.73. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on RHHBY shares. UBS Group upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Morgan Stanley assumed coverage on shares of Roche in a research report on Wednesday, February 12th. They issued an “equal weight” rating for the company. Finally, Sanford C. Bernstein raised shares of Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.